86 related articles for article (PubMed ID: 21411322)
1. Potential CRF1R PET imaging agents: N-fluoroalkyl-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethyl-N-alkylpyrazolo[1,5-a][1,3,5]triazin-4-amines.
Zuev D; Mattson RJ; Huang H; Mattson GK; Zueva L; Nielsen JM; Kozlowski ES; Huang XS; Wu D; Gao Q; Lodge NJ; Bronson JJ; Macor JE
Bioorg Med Chem Lett; 2011 Apr; 21(8):2484-8. PubMed ID: 21411322
[TBL] [Abstract][Full Text] [Related]
2. Potential CRF1R PET imaging agents: 1-fluoroalkylsubstituted 5-halo-3-(arylamino)pyrazin-2(1H)-ones.
Denhart DJ; Zuev D; Ditta JL; Hartz RA; Ahuja VT; Mattson RJ; Huang H; Mattson GK; Zueva L; Nielsen JM; Kozlowski ES; Lodge NJ; Bronson JJ; Macor JE
Bioorg Med Chem Lett; 2013 Apr; 23(7):2052-5. PubMed ID: 23465610
[TBL] [Abstract][Full Text] [Related]
3. Pyrrolo[1,2-b]pyridazines, pyrrolo[2,1-f]triazin-4(3H)-ones, and related compounds as novel corticotropin-releasing factor 1 (CRF₁) receptor antagonists.
Saito T; Obitsu T; Kohno H; Sugimoto I; Matsushita T; Nishiyama T; Hirota T; Takeda H; Matsumura N; Ueno S; Kishi A; Kagamiishi Y; Nakai H; Takaoka Y
Bioorg Med Chem; 2012 Jan; 20(2):1122-38. PubMed ID: 22196514
[TBL] [Abstract][Full Text] [Related]
4. Synthesis toward CRHR1 Antagonists through 2,7-Dimethylpyrazolo[1,5-α][1,3,5]triazin-4(3H)-one C-H Arylation.
Long J; Lee WS; Chough C; Bae IH; Kim BM
J Org Chem; 2015 May; 80(9):4716-21. PubMed ID: 25856509
[TBL] [Abstract][Full Text] [Related]
5. Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists.
Chen C; Wilcoxen KM; Huang CQ; Xie YF; McCarthy JR; Webb TR; Zhu YF; Saunders J; Liu XJ; Chen TK; Bozigian H; Grigoriadis DE
J Med Chem; 2004 Sep; 47(19):4787-98. PubMed ID: 15341493
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors.
Hoepping A; Diekers M; Deuther-Conrad W; Scheunemann M; Fischer S; Hiller A; Wegner F; Steinbach J; Brust P
Bioorg Med Chem; 2008 Feb; 16(3):1184-94. PubMed ID: 18023192
[TBL] [Abstract][Full Text] [Related]
7. A novel series of positive modulators of the AMPA receptor: structure-based lead optimization.
Jamieson C; Campbell RA; Cumming IA; Gillen KJ; Gillespie J; Kazemier B; Kiczun M; Lamont Y; Lyons AJ; Maclean JK; Martin F; Moir EM; Morrow JA; Pantling J; Rankovic Z; Smith L
Bioorg Med Chem Lett; 2010 Oct; 20(20):6072-5. PubMed ID: 20817521
[TBL] [Abstract][Full Text] [Related]
8. 4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist.
He L; Gilligan PJ; Zaczek R; Fitzgerald LW; McElroy J; Shen HS; Saye JA; Kalin NH; Shelton S; Christ D; Trainor G; Hartig P
J Med Chem; 2000 Feb; 43(3):449-56. PubMed ID: 10669572
[TBL] [Abstract][Full Text] [Related]
9. 8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists.
Gilligan PJ; He L; Clarke T; Tivitmahaisoon P; Lelas S; Li YW; Heman K; Fitzgerald L; Miller K; Zhang G; Marshall A; Krause C; McElroy J; Ward K; Shen H; Wong H; Grossman S; Nemeth G; Zaczek R; Arneric SP; Hartig P; Robertson DW; Trainor G
J Med Chem; 2009 May; 52(9):3073-83. PubMed ID: 19361210
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists.
Gilligan PJ; Clarke T; He L; Lelas S; Li YW; Heman K; Fitzgerald L; Miller K; Zhang G; Marshall A; Krause C; McElroy JF; Ward K; Zeller K; Wong H; Bai S; Saye J; Grossman S; Zaczek R; Arneric SP; Hartig P; Robertson D; Trainor G
J Med Chem; 2009 May; 52(9):3084-92. PubMed ID: 19361209
[TBL] [Abstract][Full Text] [Related]
11. Optimization of CRF1R binding affinity of 2-(2,4,6-trichlorophenyl)-4-trifluoromethyl-5-aminomethylthiazoles through rapid and selective parallel synthesis.
Zuev D; Michne JA; Pin SS; Zhang J; Taber MT; Dubowchik GM
Bioorg Med Chem Lett; 2005 Jan; 15(2):431-4. PubMed ID: 15603967
[TBL] [Abstract][Full Text] [Related]
12. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
[TBL] [Abstract][Full Text] [Related]
13. Receptor occupancy of nonpeptide corticotropin-releasing factor 1 antagonist DMP696: correlation with drug exposure and anxiolytic efficacy.
Li YW; Hill G; Wong H; Kelly N; Ward K; Pierdomenico M; Ren S; Gilligan P; Grossman S; Trainor G; Taub R; McElroy J; Zazcek R
J Pharmacol Exp Ther; 2003 Apr; 305(1):86-96. PubMed ID: 12649356
[TBL] [Abstract][Full Text] [Related]
14. Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists.
Lowe RF; Nelson J; Dang TN; Crowe PD; Pahuja A; McCarthy JR; Grigoriadis DE; Conlon P; Saunders J; Chen C; Szabo T; Chen TK; Bozigian H
J Med Chem; 2005 Mar; 48(5):1540-9. PubMed ID: 15743196
[TBL] [Abstract][Full Text] [Related]
15. Novel protoporphyrinogen oxidase inhibitors: 3H-pyrazolo[3,4-d][1,2,3]triazin-4-one derivatives.
Li HB; Zhu YQ; Song XW; Hu FZ; Liu B; Li YH; Niu ZX; Liu P; Wang ZH; Song HB; Zou XM; Yang HZ
J Agric Food Chem; 2008 Oct; 56(20):9535-42. PubMed ID: 18808144
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and amine transporter affinities of novel phenyltropane derivatives as potential positron emission tomography (PET) imaging agents.
Peng X; Zhang A; Kula NS; Baldessarini RJ; Neumeyer JL
Bioorg Med Chem Lett; 2004 Nov; 14(22):5635-9. PubMed ID: 15482938
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.
Nielsen DM; Carey GJ; Gold LH
Eur J Pharmacol; 2004 Sep; 499(1-2):135-46. PubMed ID: 15363960
[TBL] [Abstract][Full Text] [Related]
18. 5-arylamino-1,2,4-triazin-6(1H)-one CRF1 receptor antagonists.
Schmitz WD; Brenner AB; Bronson JJ; Ditta JL; Griffin CR; Li YW; Lodge NJ; Molski TF; Olson RE; Zhuo X; Macor JE
Bioorg Med Chem Lett; 2010 Jun; 20(12):3579-83. PubMed ID: 20483614
[TBL] [Abstract][Full Text] [Related]
19. Pt(II)-mediated nitrile-tetramethylguanidine coupling as a key step for a novel synthesis of 1,6-dihydro-1,3,5-dihydrotriazines.
Gushchin PV; Bokach NA; Luzyanin KV; Nazarov AA; Haukka M; Kukushkin VY
Inorg Chem; 2007 Mar; 46(5):1684-93. PubMed ID: 17266300
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists.
Gross RS; Guo Z; Dyck B; Coon T; Huang CQ; Lowe RF; Marinkovic D; Moorjani M; Nelson J; Zamani-Kord S; Grigoriadis DE; Hoare SR; Crowe PD; Bu JH; Haddach M; McCarthy J; Saunders J; Sullivan R; Chen T; Williams JP
J Med Chem; 2005 Sep; 48(18):5780-93. PubMed ID: 16134945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
